A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma
Clinical trial NCT02078102 · COMPLETED
Trial details
- NCT number
- NCT02078102
- Sponsor
- Sherif S. Farag
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-11
- Primary completion
- 2018-11-06
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.